bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

  Health Highlights: Nov. 28, 2016

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Bill Seeks to Speed Approval of New Drugs, Therapies

A bill meant to speed approval of new drugs and medical devices in the United States is scheduled for a vote in the House of Representatives this week.

The $6.3 billion bill, which also aims to increase biomedical research, would streamline how federal regulators assess the safety of new therapies in order to make them available to patients sooner, the Associated Press reported.

The bill would provide new money for the National Institutes of Health ($4.8 billion) and the Food and Drug Administration ($500 million), as well as $1 billion in grants to states to fight opioid abuse.

Republicans said the measure was final, but aides to Democrats said discussions were still ongoing, the AP reported.

-----

HIV Vaccine Clinical Trial Begins in South Africa

An experimental HIV vaccine being tested in a clinical trial in South Africa could be the "final nail in the coffin" for the AIDS-causing virus, according to a U.S. government official.

The trial begins Wednesday and seeks to enroll 5,400 sexually active men and women, ages 18-35, at 15 sites across South Africa, the Associated Press reported.

The vaccine in the new trial is based on one used in a 2009 trial in Thailand that was found to be 31.2 percent effective at preventing HIV infection for 3.5 years after vaccination.

The new vaccine was created to provide stronger and longer protection, and was adapted to the HIV subtype that predominates in southern Africa. Each day in South Africa, more than 1,000 people are infected with HIV, the AP reported.

"If deployed alongside our current armory of proven HIV prevention tools, a safe and effective vaccine could be the final nail in the coffin for HIV," Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said in a statement.

"Even a moderately effective vaccine would significantly decrease the burden of HIV disease over time in countries and populations with high rates of HIV infection, such as South Africa," he said, the AP reported.

Copyright © 2016 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=717213

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Specialty Chemicals and Products
Infection
Equipment and Supplies
HIV Infections
Hypersensitivity
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact